SCHEMBL29979103

SCHEMBL29979103

CCC1CCCCN1c1ccc(Cl)cc1NS(=O)(=O)c1ccc(S(=O)(=O)N(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCOLN2 Q8IZK6 1/20 0.46
PSEN1 P49768 2/20 0.45
PSEN2 P49810 2/20 0.45
APH1B Q8WW43 2/20 0.45
NCSTN Q92542 2/20 0.45
APH1A Q96BI3 2/20 0.45
PSENEN Q9NZ42 2/20 0.45
ALDH1A1 P00352 8/20 0.43
GAA P10253 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
HTT P42858 2/20 0.43
KMT2A Q03164 4/20 0.42
LMNA P02545 3/20 0.42
MAPT P10636 3/20 0.42
MEN1 O00255 2/20 0.42
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29978996 0.89 ALDH1A1 (0.44) MCOLN2ALDH1A1GAAL3MBTL1HTT
SCHEMBL23057221 0.81 MCOLN2 (0.67) MCOLN2PSEN1PSEN2APH1BNCSTN
SCHEMBL29978639 0.78 ALDH1A1 (0.55) MCOLN2ALDH1A1GAAL3MBTL1HTT
SCHEMBL23057226 0.78 ALDH1A1 (0.55) MCOLN2ALDH1A1GAAL3MBTL1HTT
SCHEMBL23057222 0.77 ALDH1A1 (0.49) MCOLN2ALDH1A1GAAL3MBTL1HTT
SCHEMBL23057110 0.77 ALDH1A1 (0.51) MCOLN2ALDH1A1GAAL3MBTL1HTT
SCHEMBL29978597 0.77 ALDH1A1 (0.47) MCOLN2ALDH1A1GAAL3MBTL1HTT
SCHEMBL29979362 0.76 MCOLN2 (0.49) MCOLN2ALDH1A1GAAL3MBTL1HTT
SCHEMBL23057264 0.75 ALDH1A1 (0.49) MCOLN2ALDH1A1GAAL3MBTL1HTT
SCHEMBL29978490 0.75 ALDH1A1 (0.49) MCOLN2ALDH1A1GAAL3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF MCOLN1, MCOLN2, MCOLN3 MCOLN2 2/4885PSEN1 520/4885PSEN2 1717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.